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Farm animals are a potential reservoir for human 
Clostridium difficile infection (CDI), particularly PCR 
ribotype 078 which is frequently found in animals 
and humans. Here, whole genome single-nucleotide 
polymorphism (SNP) analysis was used to study the 
evolutionary relatedness of C. difficile 078 isolated 
from humans and animals on Dutch pig farms. All 
sequenced genomes were surveyed for potential anti-
microbial resistance determinants and linked to an 
antimicrobial resistance phenotype. We sequenced the 
whole genome of 65 C. difficile 078 isolates collected 
between 2002 and 2011 from pigs (n = 19), asymp-
tomatic farmers (n = 15) and hospitalised patients 
(n = 31) in the Netherlands. The collection included 12 
pairs of human and pig isolates from 2011 collected at 
12 different pig farms. A mutation rate of 1.1 SNPs per 
genome per year was determined for C. difficile 078. 
Importantly, we demonstrate that farmers and pigs 
were colonised with identical (no SNP differences) and 
nearly identical (less than two SNP differences) C. dif-
ficile clones. Identical tetracycline and streptomycin 
resistance determinants were present in human and 
animal C. difficile 078 isolates. Our observation that 
farmers and pigs share identical C. difficile strains 
suggests transmission between these populations, 
although we cannot exclude the possibility of trans-
mission from a common environmental source.  
Introduction
In the past decade Clostridium difficile has emerged 
rapidly to become the most common cause of antibiotic-
associated diarrhoea in healthcare facilities worldwide. 
Antibiotic treatment, advanced age and hospitalisation 
are the major risk factors for developing C. difficile 
infection (CDI) leading to diarrhoea, pseudomembra-
nous colitis or death [1,2]. CDI is increasingly recog-
nised in the community setting [3-6] where exposure to 
antibiotics is an important risk factor [5], while the use 
of proton pump inhibitors [4], outpatient healthcare 
exposure [7], obesity and inflammatory bowel disease 
(IBD) [8] are potential risk factors. C. difficile virulence 
is primarily mediated by two potent enterotoxins, TcdA 
and TcdB, which are encoded in a pathogenicity locus 
(PaLoc) [9-11]. The binary toxin may contribute to the 
virulence of C. difficile as well [12], but its role in CDI 
is still under debate [13-16]. C. difficile produces highly 
resistant and infectious spores, which can survive in 
the environment for a long time and facilitate environ-
mental transmission within the healthcare setting [17].
Symptomatic individuals are an important source of 
C. difficile transmission in a hospital setting, and 
patient isolation and antibiotic stewardship have been 
proven to be effective infection control measures 
[18,19]. The role of asymptomatic carriers as donors 
of transmission may also be significant [20-23], and 
diverse novel subtypes are continuously introduced 
in the healthcare system, highlighting a link to a large 
and diverse community reservoir [24]. Interestingly, C. 
difficile PCR ribotype 078, which is commonly found in 
the healthcare system of various European countries 
[25], is more often associated with community-acquired 
CDI [26]. Notably, this variant is the most common type 
found in pigs [27-30] and other farm animals [31-33].
Several studies have reported an overlap between C. 
difficile genotypes isolated from humans and animals 
[27,34-38] using conventional typing methods such as 
PCR ribotyping, multilocus sequence typing (MLST), 
and multilocus variable-number tandem repeat analy-
sis (MLVA). However, these methods do not have the 
discriminatory power to distinguish between closely 
related strains as is required for transmission tracking. 
In this study, we used whole genome sequencing and 
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phylogenetic analysis to track single clones in human 
and animal populations to demonstrate potential inter-
species transmission.
Methods
Collection of Clostridium difficile isolates
In total, the genomes of 65 isolates designated PCR 
ribotype 078 were sequenced and analysed. Of these 
65 isolates, 34 were derived from healthy humans 
(n=15) and pigs (n=19) on 19 Dutch pig farms (farm 
isolates) and 31 from hospitalised patients in various 
Dutch hospitals. Of the farm isolates, 24 isolates were 
paired by farm (i.e. 12 pairs of human and pig isolates 
from 12 farms), whereas the remaining 10 (from three 
farmers and seven pigs) were not paired. The major-
ity of the farm isolates were collected in 2011 by the 
Institute for Risk Assessment Sciences of the Utrecht 
Figure 1
Transmission events and phylogeny of Clostridium difficile 078, the Netherlands 2002–11 (n=65)
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A. Distribution of Dutch hospitals and pig farms included in this study. Only pig farms with a known location were plotted. Blue dots represent 
the hospitals (n = 16) where isolates from hospitalised patients were obtained, red dots represent pig farms (n = 12) where isolates from 
farmers and pigs were obtained. Brown dots represent the pig farms where pigs and farmers had identical C. difficile isolates. The green 
arrow indicates a potential (long-range) transmission event between two farms.
B. Phylogenetic tree revealing likely transmission between pigs and humans. Shown is the reconstructed phylogenetic tree based on 774 
core genome single-nucleotide polymorphisms (SNPs). Samples are colour-coded according to their source: pig (red), farmer (green) and 
clinical isolate (blue). Identical genotypes with an epidemiological link (i.e. same location/farm) are marked with brown boxes. Long-
range transmission events (i.e. different locations) are marked with a green box. The tip labels are coded with the city name followed by 
two numbers that represent year of isolation (’08  2008). The CDM120 genome (purple) is used for the reference-based mapping, RT066 
(purple) is used as an out-group to root the tree. The scale indicates the branch length that correspond to 10 SNP differences. The numbers 
for the internal nodes show the support from 100 non-parametric bootstraps of a maximum likelihood reconstruction (only bootstrap 
values > 50 are shown).
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University as part of another study [34]. Thirty-one 
randomly selected clinical isolates originating from 
various Dutch hospitals between 2002 and 2011 were 
obtained from the Dutch National C. difficile reference 
laboratory at Leiden University Medical Center. In addi-
tion, one PCR ribotype 066 strain was included; this 
strain was obtained from our Leeds-Leiden/European 
Centre for Disease Prevention and Control (ECDC) ref-
erence strain collection [39]. Details of all sequenced 
isolates are listed in Table 1, including the European 
Nucleotide Archive (ENA) sample accession numbers. 
Two isolates were sequenced in duplicate.
Bacterial culture and genomic DNA 
preparation
C. difficile was cultured on blood agar plates 
(BioMérieux, the Netherlands), inoculated into liquid 
medium (brain–heart infusion (BHI) broth supple-
mented with yeast extract and cysteine) and grown 
over night (ca 16 hours) anaerobically at 37 °C. Cells 
were pelleted, washed with phosphate-buffered saline 
(PBS), and genomic DNA preparation was performed 
using a phenol–chloroform extraction as previously 
described [40].
Whole genome sequencing
Paired-end multiplex libraries were created as previ-
ously described [41]. Sequencing was performed on 
an Illumina HiSeq 2000 platform, with a read length of 
100 bp.
In silico MLST
The alleles for the seven housekeeping genes used for 
C. difficile MLST [42] (http://pubmlst.org/cdifficile/), 
adk, atpA, dxr, glyA, recA, sodA, and tpi, were ana-
lysed in silico to determine the sequence type (ST). 
All sequenced genomes were aligned with the CDM120 
genome using the multiple sequence alignment editor 
Seaview [43], after which each individual MLST allele 
was analysed for sequence variation.
SNP calling and recombination detection
Illumina sequence data were mapped to the C. diffi-
cile 078 reference genome, M120, (European Molecular 
Biology Laboratory (EMBL) accession number: 
FN665653) as paired-end reads using SMALT software 
(http://smalt.sourceforge.net/), and SNPs were iden-
tified as previously described [41]. A potential con-
founder within the downstream phylogenetic analysis 
is the effect of homologous recombination, which has 
the potential to interfere with the phylogenetic signal 
within the dataset. To alleviate this problem we used 
the approach developed by Croucher et al. [40] to 
identify regions in the genome of each isolate where 
there was evidence of recombination. We then removed 
those sites from our alignments used in downstream 
analyses.
Phylogeny and detection of non-phylogenetic 
SNPs
Phylogenetic trees were constructed using RAxML 
[44] with a general time reversible (GTR) model with a 
gamma correction for among-site rate variation com-
bined with 100 random bootstrap replicates (default). 
Finally, metadata (source, year of isolation, geographi-
cal location) was transferred to the reconstructed tree.
Mutation rate estimation
The mutation rate across the population was estimated 
using the Bayesian evolutionary analysis sampling 
trees (BEAST) software v1.7.5 [45]. BEAST operates by 
utilising an explicit model of evolution to compute the 
mutation rate on each branch of a phylogenetic tree. 
This enables the translation of evolutionary time into 
calendar units: days or years. In order to ensure that the 
dataset was converging consistently, three independ-
ent Markov chain Monte Carlo (MCMC) chains were run, 
each of 100,000,000 states. From these, we removed 
an initial 10% as a burn-in (10,000,000 states) for each 
chain and joined the chains using LogCombiner (part of 
the BEAST suite), taking a sample every 10,000 states.
Genome-wide scan for antimicrobial resistance 
determinants
De novo assembly was performed for each sequenced 
genome using the Velvet assembler [46]. The assem-
bled contigs were then ordered against the reference 
genome M120 using ABACAS [47], which was required 
for downstream analysis using Artemis Comparison 
Tool (ACT) [48]. The ordered contigs were used to per-
form BLAST homology searches for transposons and 
antimicrobial resistance determinants. The results 
of this analysis and the discovery of novel potential 
transposons were visualised using ACT [48]. In addi-
tion, the presence of antimicrobial resistance deter-
minants located on the identified transposons were 
confirmed using the ResFinder 2.1 server [49], with an 
98% threshold for identity.
Antibiotic resistance
The minimum inhibitory concentration (MIC) for tet-
racycline was determined using E-test (BioMérieux, 
the Netherlands) on Brucella plates (Mediaproducts 
BV, the Netherlands) under anaerobic conditions at 
37 °C. Streptomycin resistance was tested by disk dif-
fusion method, using Sensi-Neotabs 500 μg disks 
(Rosco, Denmark). Results were interpreted using the 
tetracycline breakpoints provided by the Clinical and 
Laboratory Standards Institute (CLSI) [50] and strepto-
mycin breakpoints from Corver et al. [51].
Results
Mutation rate of Clostridium difficile 078 from 
the Netherlands
We performed whole genome sequencing on 65 C. dif-
ficile 078 strains isolated between 2002 and 2011 from 
various sources (animal or human) and locations in the 
Netherlands (Figure 1A; Table 1). The human isolates 
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(n = 46) were obtained either from hospitalised patients 
suffering from CDI (n = 31) or from asymptomatic colo-
nised humans working on Dutch pig farms (n = 15). 
C. difficile 078 was also isolated from asymptomatic 
pigs (n = 19). In total, 12 pairs of pig/farmer isolates 
were included, collected at the same time from the 
same farms where the sampled farmers resided and 
worked.
We initially compared the genotypes of the C. difficile 
078 isolates with MLST, the traditional gold standard 
for epidemiological typing of bacterial pathogens. 
MLST analysis was done using the DNA sequences of 
seven housekeeping genes [42], which were extracted 
from the whole-genome dataset. The concatenated 
sequence length of the MLST loci (3,501 nt) represents 
ca 0.09% of the whole genome. Our results demon-
strated that all of the C. difficile 078 isolates belonged 
to ST11, and did therefore not provide a degree of reso-
lution that could be used to track and understand the 
spread of this organism (data not shown).
To increase the discriminatory power of the analysis, 
we mapped the whole genome data for each sequenced 
isolate to the C. difficile 078 reference genome M120 
[52] and identified all SNPs. Using this approach 
we identified 3,927 SNPs within the non-repetitive 
genome (95.2% of the entire genome). Of these, 3,153 
SNPs were identified as acquired through horizontal 
gene transfer or homologous recombination. These 
SNPs were removed as they disrupt the true phylog-
eny, leaving a clonal frame of 774 phylogenetically 
informative SNPs for further downstream analysis. Of 
these, 373 SNPs were found only in the C. difficile 066 
isolate (ST11), a close relative of C. difficile 078 [39], 
which was used to root the phylogenetic tree. A pop-
ulation-specific mutation rate of C. difficile 078 was 
estimated, using the isolation dates of our sequenced 
samples for calibrating the time scale of the phyloge-
netic tree. Based on our collection, the mutation rate 
for the C. difficile 078 lineage was estimated to be 2.72 
x 10-7 substitutions per site per year (95% confidence 
interval (CI): 1.43 x 10-7–3.99 x 10-7) which is equiva-
lent to 1.1 SNP per genome per year (95% CI: 0.6–1.6) 
when multiplied by the number of sites present in the 
C. difficile 078 genome. This mutation rate is compara-
ble to published estimates for C. difficile 027 [53] and 
genomes obtained from a selection of 24 distinct STs 
[54].
Identical genotypes in humans and farm animals
In order to study potential transmission of C. difficile 
078 between farm animals and humans, we compared 
12 pairs of farmer and pig strains by whole genome 
SNP typing (Table 2). Interestingly, three farmer/
pig pairs, collected at three farms located in Heino, 
Aarle-Rixtel and Moergestel, shared identical geno-
types, i.e. had no SNP differences (Table 2).  In addi-
tion, two pairs collected at farms in Hardenberg and 
Houten were separated by only one SNP difference. 
In all probability, one SNP difference is indicative of a 
very recent potential transmission event (less than one 
year earlier). Consequently, using one SNP difference 
as a threshold for defining suspected transmission on 
farms, the number of potential transmission events 
between farmers and animals increased to five, repre-
senting five of the 12 sequenced farmer/pig pairs. Of 
the remaining seven paired samples, only two differed 
more than 10 SNPs, whereas five had three (n = 3), four 
(n = 1) or seven (n = 1) SNP differences. The paired ani-
mal and human samples with only three to four SNP 
differences could suggest that a potential transmis-
sion event occurred a few years before, and from that 
moment, the bacterium evolved separately inside dif-
ferent hosts. The paired isolates with more than 10 
SNPs difference were genetically so diverse that direct 
transmission was ruled out.
Population structure of Clostridium difficile 
078 in the Netherlands
To study the closely related paired farm isolates in a 
broader evolutionary context, we compared the 12 
pairs with 41 additional C. difficile samples that were 
epidemiologically unrelated to the farm isolates and 
collected over a longer period of time. These 41 sam-
ples included 10 individual (i.e. unpaired) farm isolates 
(from three farmers and seven pigs) collected between 
2009 and 2011, and 31 independent (i.e. non-outbreak) 
clinical isolates obtained from hospitalised patients 
suffering from CDI collected at various Dutch hospi-
tals between 2002 and 2011. According to the defini-
tions described by Kuijper et al. [55], the majority of 
these clinical isolates (n = 23) were defined as health-
care-associated cases, while two cases were defined 
as community-associated; for six clinical isolates the 
onset was unknown (Table 1).
A maximum likelihood phylogeny was generated using 
the 401 phylogenetic SNPs identified in the genomes of 
the 65 sequenced isolates (Figure 1B). In total, 61 dis-
tinct SNP genotypes were observed among the 65 C. dif-
ficile 078 isolates. Two isolates (Oirschot ’11 and Leiden 
‘06) at the periphery of the phylogenetic tree differed 
by 49 SNPs, which gave an indication of the extent of 
variation present in the phylogeny. Interestingly, the 
inferred phylogeny of Dutch C. difficile 078 revealed a 
general lack of clustering related to strain source (i.e. 
swine, farmer or clinical), as demonstrated by the min-
gling of strain sources in the phylogenetic tree (Figure 
1B). Isolates from the same source group did not form 
distinct clusters, while several distinct heterogeneous 
groups were observed that included isolates obtained 
from diverse sources. This was especially apparent in 
the cluster consisting of a clinical isolate (Breda ‘08), 
a pig isolate (R’donksv.’11) and two farmer isolates 
(Oirschot ’11 and R’donksv.’11) that were all collected 
in the same region (Noord Brabant) of the Netherlands 
(Figure 2). Interestingly, only four SNP differences 
separated the clinical isolate (Breda ’08) from the near-
est farm isolate (R’donksv.’11). Given the three year 
window in which these isolates were collected and 
the estimated mutation rate of 1.1 SNP difference per 
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Table 1A
Clostridium difficile type 078 isolates used in this study, the Netherlands, 2002–11 (n=65)
R_L#Ta Year City RT Isolate Source Related isolates Association ENA IDb
8080_2#24 2006 Leiden 078 6072310 Clinic Non-outbreak Healthcare ERS138026
8080_2#25 2006 Nijmegen 078 6086336 Clinic Non-outbreak Healthcare ERS138027
8080_2#26 2007 Leiden 078 7001233 Clinic Non-outbreak Healthcare ERS138028
8080_2#27 2007 Groningen 078 7004578 Clinic Non-outbreak Unknown ERS138029
8080_2#28 2007 Utrecht 078 7005405 Clinic Non-outbreak Unknown ERS138030
8080_2#29 2007 Zwolle 078 7021455 Clinic Non-outbreak Healthcare ERS138031
8080_2#30 2007 Zwolle 078 7044912 Clinic Non-outbreak Community ERS138032
8080_2#31 2007 Zwolle 078 7066827 Clinic Non-outbreak Community ERS138033
8080_2#32 2007 Zwolle 078 7071308 Clinic Non-outbreak Healthcare ERS138034
8080_2#33 2007 Zwolle 078 7086074 Clinic Non-outbreak Healthcare ERS138035
8080_2#34 2007 Leiden 078 7091952 Clinic Non-outbreak Healthcare ERS138036
8080_2#35 2008 Leiden 078 8011061 Clinic Non-outbreak Healthcare ERS138037
8080_2#36 2008 Utrecht 078 8013820 Clinic Non-outbreak Healthcare ERS138038
8080_2#37 2008 Leiden 078 8051728 Clinic Non-outbreak Healthcare ERS138039
8080_2#38 2008 Leiden 078 8055344 Clinic Non-outbreak Healthcare ERS138040
11250_1#22 2008 Arnhem 078 8056692 Clinic Non-outbreak Unknown ERS362924
8080_2#40 2008 Breda 078 8091554 Clinic Non-outbreak Healthcare ERS138042
8080_2#41 2009 Harderwijk 078 9012668 Clinic Non-outbreak Healthcare ERS138043
8080_2#42 2009 Goes 078 9019497 Clinic Non-outbreak Unknown ERS138044
8080_2#43 2009 Hoorn 078 9077637 Clinic Non-outbreak Healthcare ERS138045
8080_2#44 2010 Roermond 078 10005075 Clinic Non-outbreak Healthcare ERS138046
8080_2#45 2010 Rotterdam 078 10015222 Clinic Non-outbreak Healthcare ERS138047
8080_2#46 2010 Velp 078 10080193 Clinic Non-outbreak Healthcare ERS138048
8080_2#47 2011 Zeeland 078 11012929 Clinic Non-outbreak Healthcare ERS138049
8080_2#49 2009 Zwolle 078 1103 Clinic Non-outbreak Unknown ERS138051
8080_2#58 NI Leeds 066 066 (root)c Clinic  Reference collection Unknown ERS138052
8080_2#61 2002 Rotterdam 078 126065 Clinic Non-outbreak Unknown ERS138053
8080_2#62 2002 Leiden 078 126819 Clinic Non-outbreak Healthcare ERS138054
8080_2#63 2002 Leiden 078 126938 Clinic Non-outbreak Healthcare ERS138055
8080_2#64 2002 Leiden 078 129820 Clinic Non-outbreak Healthcare ERS138056
8080_2#71 2010 Leiden 078 53737 Clinic Non-outbreak Healthcare ERS138060
8080_2#72 2007 Haarlem 078 47337 Clinic Non-outbreak Healthcare ERS138063
8080_2#50 2009 Gastel 078 P29 Pig Un-paired Farm ERS138064
8080_2#51 2009 NI 078 P60 Pig Un-paired Farm ERS138065
8080_2#52 2009 Flevoland 078 P27 Pig Un-paired Farm ERS138066
8080_2#53 2009 NI 078 P70 Pig Un-paired Farm ERS138069
8080_2#54 2009 Tolakker 078 P52 Pig Un-paired Farm ERS138070
8080_2#67 2011 Aarle-Rixtel 078 H205d Farmer Pair 1 Farm ERS138073
8080_2#68 2011 Aarle-Rixtel 078 B37_2e Pig Pair 1 Farm ERS138074
9221_6#55 2011 NI 078 H102 Farmer Pair 12 Farm ERS199786
9221_6#56 2011 Raamsdonksveer 078 B31_3 Pig Pair 9 Farm ERS199787
9221_6#57 2011 Heino 078 B17_3 Pig Pair 4 Farm ERS199788
9221_6#58 2011 Ulft 078 H121 Farmer Pair 11 Farm ERS199789
9221_6#59 2011 Rijen 078 B27_7 Pig Pair 10 Farm ERS199790
9221_6#60 2011 Baarle-Nassau 078 H230 Farmer Pair 2 Farm ERS199791
9221_6#61 2011 Oirschot 078 H189 Farmer Pair 8 Farm ERS199792
9221_6#62 2011 Lierop 078 B23_6 Pig Pair 6 Farm ERS199793
NI: not identified; RT: ribotyope.
a  R_L#T, run, lane and tag number.
b  European Nucleotide Archive sample submission number.
c  Included as root sequence.
d,e Sequenced in duplicate.
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genome per year (95% CI: 0.6–1.6), one would expect 
to observe two to four SNP differences (prediction 
interval: 1.8–4.8) between these isolates in case of 
transmission during this time. Therefore, the observed 
four SNP difference in this cluster suggests a possible 
transmission link between farm and clinical isolates.
The phylogenetic tree also demonstrated a general 
lack of geographic clustering (Figure 1B). This is partic-
ularly evident for the isolates from Leiden and Zwolle 
that were dispersed throughout the phylogeny. This 
observation suggested that related C. difficile 078 
strains were widely distributed across the country 
and were frequently transmitted between locations. 
Interestingly, the analysis revealed two farmers with 
no obvious epidemiological link that were colonised 
with identical C. difficile 078 isolates (Figure 1B; green 
box). The farms were located at Lierop and Ulft (ca 100 
km apart), emphasising the lack of geographic signal 
in these results.
Tetracycline and streptomycin resistance 
determinants are shared between Clostridium 
difficile 078 strains from humans and pig
C. difficile genomes carry a broad array of mobile 
genetic elements that are not included in our 
phylogenetic SNP analysis but often encode clinically 
relevant phenotypes such as antimicrobial resistance 
(AMR). We assembled and analysed the C. difficile 078 
genomes to identify potential mobile elements contain-
ing AMR determinants and then mapped these onto 
the phylogenetic tree. We observed the presence of a 
mobile element with high homology (92.7%) to a pre-
viously described transposon Tn6190 [51] and a novel 
potential transposon that was designated as Tn6235 in 
this study (data not shown). These transposons poten-
tially confer resistance to various antibiotics, including 
tetracycline, and each transposon grouped into dis-
tinct phylogenetic clusters (Figure 3).
Mobile element Tn6190, harbouring tetracycline resist-
ance determinant tetM (EMBL accession number: 
EU182585.1; 98.9% identity), was present in 24 of the 
sequenced genomes that were obtained from diverse 
hosts. The majority of these 24 genomes grouped 
together in a monophylogenetic cluster (Figure 3; 
orange dots). Tetracycline susceptibility testing con-
firmed that the presence of tetM correlated with 
tetracycline resistance (Figure 3 orange branches; 
Table 3). The novel mobile element Tn6235 was pre-
sent in its full length (ca 40 kb; 100% homology) in 
10 sequenced C. difficile 078 genomes that formed a 
Table 1B
Clostridium difficile type 078 isolates used in this study, the Netherlands, 2002–11 (n=65)
R_L#Ta Year City RT Isolate Source Related isolates Association ENA IDb
9221_6#63 2011 Aarle-Rixtel 078 H205d Farmer Duplicate Farm ERS199794
9221_6#64 2011 Hardenberg 078 B15_1 Pig Pair 3 Farm ERS199795
9221_6#65 2011 Oirschot 078 H21 Farmer Un-paired Farm ERS199796
9221_6#66 2011 Oirschot 078 B30_5 Pig Pair 8 Farm ERS199797
9221_6#67 2011 Rijen 078 H122 Farmer Pair 10 Farm ERS199798
9221_6#68 2011 Hardenberg 078 H95 Farmer Pair 3 Farm ERS199799
9221_6#69 2011 Raamsdonk 078 B28_1 Pig Un-paired Farm ERS199800
9221_6#70 2011 Bakel 078 H214 Farmer Un-paired Farm ERS199801
9221_6#71 2011 Raamsdonksveer 078 H158 Farmer Pair 9 Farm ERS199802
9221_6#72 2011 Heino 078 H88 Farmer Pair 4 Farm ERS199803
9221_6#73 2011 Lemele 078 H111 Farmer Un-paired Farm ERS199804
9221_6#74 2011 Baarle-Nassau 078 B39_4 Pig Pair 2 Farm ERS199805
9221_6#75 2011 Moergestel 078 B4_2 Pig Pair 7 Farm ERS199806
9221_6#76 2011 NI 078 B20_1 Pig Pair 12 Farm ERS199807
9221_6#77 2011 Moergestel 078 H16 Farmer Pair 7 Farm ERS199808
9221_6#78 2011 Aarle-Rixtel 078 B37_3e Pig Duplicate Farm ERS199809
9221_6#79 2011 Ermelo 078 B1_5 Pig Un-paired Farm ERS199810
9221_6#80 2011 Lierop 078 H170 Farmer Pair 6 Farm ERS199811
9221_6#81 2011 Ulft 078 B22_6 Pig Pair 11 Farm ERS199812
9221_6#82 2011 Houten 078 B29_10 Pig Pair 5 Farm ERS199813
9221_6#83 2011 Houten 078 H141 Farmer Pair 5 Farm ERS199814
NI: not identified; RT: ribotyope.
a  R_L#T, run, lane and tag number.
b  European Nucleotide Archive sample submission number.
c  Included as root sequence.
d,e Sequenced in duplicate.
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distinct monophylogenetic cluster with strains from 
various sources (Figure 3; purple dots). Blast homol-
ogy searches of this genomic region revealed an open 
reading frame with homology (100% identity) to a 
putative aminoglycoside 3’-phosphotransferase aphA1 
(M26832) which may confer streptomycin resistance. 
Streptomycin susceptibility testing confirmed that all 
10 isolates present in the monophylogenetic cluster 
were streptomycin-resistant (Figure 3 purple branches; 
Table 3).
Discussion
We used whole genome sequencing and phylogenetic 
SNP analysis to study the overlap of C. difficile 078 
genotypes in animals and humans. In three cases, 
Dutch farmers were colonised with identical C. difficile 
078 clones as pigs kept on the same farms. We have 
also shown that the presence of clonal strains in pigs 
and farmers was common, as demonstrated by the 
number of farmer/pig pairs (five of 12) where clonality 
(defined as ≤ 1 SNP difference) was observed.
The clonal C. difficile 078 strains in farmers and farm 
animals that were identified indicate that interspe-
cies transmission has occurred, although we cannot 
Figure 2
Phylogenetic cluster showing relatedness of Clostridium 
difficile clinical, pig and farmer isolates, the Netherlands, 
2008–11 (n=4)
Farm
1
2
2
Hospital
2
1NoordBrabantBreda
Oirschot
R’donksv. R’donkveer ‘11
Breda ‘08
Oirschot ‘11
R’donksveer ‘11
A B
A. Geographical map showing the location of the isolates 
present in the phylogenetic cluster shown in panel B. Blue dot 
represents a hospital (Breda), red dots represent the two pig 
farms (R’donksv. and Oirschot). 
B. Zoom-in on a phylogenetic cluster containing highly related 
isolates from different sources (swine, farmer and clinical 
isolates). The numbers on the tree branches represent the 
number of single-nucleotide polymorphisms differences in the 
cluster, the tip labels are coded with city (Breda) followed by two 
numbers that represent year of isolation (’08  2008).
Table 2
Single nucleotide polymorphism differences between paired farm isolates of Clostridium difficile 078, the Netherlands 
2009–11 (n=24)
Pair number R_L#Ta Location of farm RT Source ID SNP differences
1
8080_268_6#78
Aarle-Rixtel
078 Pig B37_2
0
8080_2#67 078 Farmer H205
2
9221_6#74
Baarle-Nassau
078 Pig B39_4
3
9221_6#60 078 Farmer H230
3
9221_6#64
Hardenberg
078 Pig B15_1
1
9221_6#68 078 Farmer H95
4
9221_6#57
Heino
078 Pig B17_3
0
9221_6#72 078 Farmer H88
5
9221_6#82
Houten
078 Pig B29_10
1
9221_6#83 078 Farmer H141
6
9221_6#62
Lierop
078 Pig B23_6
4
9221_6#80 078 Farmer H170
7
9221_6#75
Moergestel
078 Pig B4_2
0
9221_6#77 078 Farmer H16
8
9221_6#66
Oirschot
078 Pig B30_5
10
9221_6#61 078 Farmer H189
9
9221_6#56
Raamsdonksveer
078 Pig B31_3
3
9221_6#71 078 Farmer H158
10
9221_6#59
Rijen
078 Pig B27_7
19
9221_6#67 078 Farmer H122
11
9221_6#81
Ulft
078 Pig B22_6
7
9221_6#58 078 Farmer H121
12
9221_6#76
NI
078 Pig B20_1
3
9221_6#55 078 Farmer H102
ID: sample identifier. RT: ribotyope.
a  R_L#T, run, lane and tag number.
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Figure 3
Phylogeny of Clostridium difficle 078 isolates showing the presence of antimicrobial resistance determinants, the 
Netherlands, 2002–11 (n=65a)
Tn6190
Tn6235
NT = not phenotypically tested. 
Circular representation of the C. difficile 078 phylogeny with coloured dots representing the distribution of antimicrobial resistance (AMR) 
determinants. The legend shows the identified transposons together with the AMR determinants (between brackets) located on the 
transposon. The coloured dotted lines represent the source of the respective isolates (swine, farmer and clinical isolate). The presence of 
Tn6190 (tetM) is associated with tetracycline resistance; 078 isolates phenotypically tested as tetracycline-resistant are indicated with 
orange tree branches, streptomycin-resistant isolates are indicated with purple tree branches, isolates resistant to both tetracycline and 
streptomycin are indicated with blue tree branches. 
a  Two isolates were sequenced in duplicate. Ne RT 066 sequence was included as root sequence. In total, 68 sequences are shown.
9www.eurosurveillance.org
exclude the possibility that they shared a common 
(environmental) exposure source, e.g. acquisition of 
spores from a shared common environmental source. 
However, we believe that direct transmission is plau-
sible. Firstly, the faecal–oral route is the main route of 
C. difficile transmission, and farmers have a high prob-
ability of exposure to pig faeces. Secondly, genomes 
with zero SNP differences were isolated from farmers 
and pigs. If acquisition of identical C. difficile strains in 
humans and animals was a result of transmission from 
a common source, then either it must have been a very 
recent environmental transmission event or it did not 
evolve inside either host after the exposure. Finally, 
the possibility of an intermediate host can be excluded 
NT: not available for testing; shown are the distribution of the mobile elements Tn6190 and Tn6235 among the 078 genomes.
Green: sensitive (S); orange: intermediate (I); red: resistant (R). 
Minimum inhibitory concentration cut-off levels used:
Table 3
Results of Antimicrobial susceptibility testing
Isolate Source Strepto-mycin Tn6235
Tetra-
cycline Tn6190
6072310 Clinic Absent Present
6086336 Clinic Absent Present
7001233 Clinic NT Absent Absent
7004578 Clinic Absent Present
7005405 Clinic Present Absent
7021455 Clinic Absent Present
7044912 Clinic Present Absent
7066827 Clinic Absent Present
7071308 Clinic Absent Absent
7086074 Clinic Absent Absent
7091952 Clinic Absent Present
8011061 Clinic Absent Absent
8013820 Clinic Absent Absent
8051728 Clinic Absent Present
8055344 Clinic Present Absent
8056692 Clinic Absent Absent
8091554 Clinic Absent Absent
9012668 Clinic Absent Absent
9019497 Clinic Absent Absent
9077637 Clinic Absent Present
10005075 Clinic Absent Present
10015222 Clinic Absent Present
10080193 Clinic Absent Present
11012929 Clinic Absent Absent
1103 Clinic NT Absent NT Present
P29 Pig NT Absent Absent
P60 Pig NT Absent Present
P27 Pig Absent Absent
P70 Pig NT Absent Absent
P52 Pig NT Absent Absent
RT066 Clinic Absent Present
126065 Clinic NT Absent NT Absent
126819 Clinic NT Absent NT Absent
126938 Clinic NT Absent NT Absent
Isolate Source Strepto-mycin Tn6235
Tetra-
cycline Tn6190
129280 Clinic Absent Absent
H205 Farmer Present Absent
B37.3 Pig Present Absent
53737 Clinic NT Absent NT Present
47337 Clinic Absent Present
H102 Farmer Absent Absent
B31.3 Pig Absent Absent
B17.3 Pig Absent Absent
H121 Farmer Absent Present
B27.7 Pig Absent Absent
H230 Farmer Absent Present
H189 Farmer Absent Absent
B23.6 Pig Absent Present
H205 Farmer Present Absent
B15.1 Pig Absent Absent
H21 Farmer Absent Absent
B30.5 Pig Absent Absent
H122 Farmer Absent Absent
H95 Pig Absent Absent
B28.1 Pig Absent Present
H214 Farmer Present Absent
H158 Farmer Absent Absent
H88 Farmer Absent Absent
H111 Farmer Present Absent
B39.4 Pig Absent Present
B4.2 Pig Absent Absent
B20.1 Pig Absent Absent
H16 Farmer Absent Absent
B37.3 Pig Present Absent
B1.5 Pig Present Absent
H170 Farmer Absent Present
B22.6 Pig Absent Present
B29.10 Pig Absent Absent
H141 Farmer Absent Absent
Antibiotic S I R
Tetracycline (µg/mL) < 4 8 ≥ 16
Streptomycin (mm) ≥ 15 NA < 15
mm: zone diameter breakpoint in mm; NA: not applicable.
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for clonal cases because circulation via an intermediate 
host for a certain period is likely to result in SNP differ-
ences. If the cases of clonal C. difficile 078 strains in 
farmers and farm animals are indeed a result of direct 
interspecies transmission, it would be informative to 
know the direction of this transmission.
The faecal–oral route of acquisition makes it logical for 
the direction to be from pig to human. In addition, the 
high carriage rates of C. difficile among farmers [34,56] 
also suggest movement from pigs to farmers. This was 
further supported by the identical antibiotic resist-
ance determinants (tetracycline and streptomycin) 
shared between animal and human strains, an obser-
vation that is in line with previous studies [35,57,58]. 
The independent insertion of Tn6235 or Tn6190 at the 
same locations in the C. difficile 078 genomes (data 
not shown) in combination with phylogenetic cluster-
ing of these isolates, suggest that Tn6235 and Tn6190 
were introduced once in a progenitor genome that has 
since then spread in both human and animal hosts. 
Interestingly, tetracycline is not frequently used in the 
Dutch healthcare system, whereas it is still the pre-
ferred pharmacotherapeutic group for the veterinary 
industry in the Netherlands [59]. This suggests that 
tetracycline resistance could be arising in C. difficile 
isolates from pigs and passed on to the human popu-
lation. Future, more systematic studies should provide 
more direct evidence for the direction of transmission.
In addition to the contribution of farm animals as a res-
ervoir for human CDI, we want to emphasise that more 
than half (58%) of our sequenced farmer/pig pairs were 
not clonal. Two of the twelve pairs had a SNP difference 
above 10 SNPs. This suggests that exposure to multi-
ple sources other than farm animals may be respon-
sible for colonisation of the farmers and their pigs. C. 
difficile can be found almost anywhere in the environ-
ment (soil, water, and potentially food) making it hard 
to pinpoint which alternative reservoirs are significant 
contributors to the spread of C. difficile 078 in the com-
munity. Currently, several potential (environmental) 
vectors of transmission have been identified, including 
but not limited to birds, insects, pets and rodents such 
as rats and mice [60-64]. Our analysis also revealed 
two farmers who were not geographically linked but 
were colonised with identical C. difficile 078 isolates. 
These had been isolated ca 100 km apart from each 
other, which could suggest exposure to a common 
environmental source. Another possible explanation 
could be transport of pigs between the two involved 
farms that resulted in indirect transmission.
We further analysed the farm isolates in a broader con-
text of clinical isolates with no obvious epidemiologi-
cal links to the farms. Our analysis demonstrated that 
all sources, farmer, pig and clinical, were distributed 
throughout the entire phylogenetic tree and no sin-
gle clusters per source were identified. These obser-
vations are in line with previous research on mixed 
human and animal C. difficile populations [35,65]. Both 
studies showed that animal isolates did not consti-
tute a distinct lineage from human isolates. A possible 
explanation for this observation is that C. difficile 078 
strains may have frequently been transmitted between 
sources, rather than persisting exclusively in one host. 
Consequently, the clonal strains in farmers and farm 
animals we identified may be part of a larger network 
that could have links with the healthcare system. The 
heterogeneous phylogenetic cluster with limited SNP 
diversity shown in Figure 2 is an example of potentially 
linked clinical and farm isolates. Additional patient 
data for the clinical isolate Breda ’08 showed that, 
although symptoms started five days before hospitali-
sation (suspected community onset), the patient was 
living in a long-term healthcare facility and therefore 
constituted a healthcare-associated case.
The strength of this study is that we applied for the 
first time the highly discriminatory method whole 
genome SNP typing to study the relatedness of C. dif-
ficile 078 isolates obtained from farmers and farm ani-
mals. A limitation of this study is the small number of 
clinical samples that were community-associated; such 
samples may have allowed us to demonstrate more 
links between farm animals, farmers and the wider 
community. In addition, the bacterial strain cohort 
was restricted to isolates obtained in one country, the 
Netherlands.
The recent trends in epidemiological data show that 
C. difficile 078 is an important type found in the Dutch 
healthcare system and its prevalence has remained 
stable between 2009 and 2013 (data not shown). 
Besides symptomatic patients, other sources play a 
major role in the spread of C. difficile within the health-
care system, for instance asymptomatic carriers visit-
ing a healthcare facility [24]. Asymptomatic carriage 
can be common among hospitalised patients [20,21], 
although future large studies are needed to determine 
the precise scale of onward transmission by these car-
riers. The reservoirs from which these carriers in the 
community are colonised remain to be elucidated. 
Importantly, it is becoming clear now that the com-
munity reservoir for human CDI is much more diverse 
and larger than previously expected [24,66]. Here, we 
demonstrate that transmission from pigs to farmers is 
one of the potential routes by which C. difficile is enter-
ing the human population, and that these isolates also 
carry antimicrobial resistance determinants that might 
be a result of selection in response to antibiotic expo-
sure in pigs. 
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